Elizabeth S O'Neill1, Stuart W Grande2, Ariel Sherman1, Glyn Elwyn2, Megan Coylewright3. 1. Section of Cardiovascular Medicine, Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH. 2. The Preference Laboratory, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH. 3. Section of Cardiovascular Medicine, Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH; The Preference Laboratory, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH. Electronic address: megan.coylewright@dartmouth.edu.
Abstract
BACKGROUND: Atrial fibrillation is a common irregular heart rhythm that increases patients' risk of stroke. Aspirin, warfarin, direct oral anticoagulants, and an implantable device can reduce this risk. Given the availability of multiple comparable options, this decision depends on patient preferences and is appropriate for the use of decision aids and other efforts to promote shared decision making. The objective of this review was to examine the existence and accessibility of, as well as select outcomes associated with, published, formally evaluated patient decision aids for stroke prevention in atrial fibrillation. METHODS: Six databases were searched from inception to March 2016 with a research librarian. Two authors independently reviewed potential articles, selected trials meeting inclusion criteria, and assessed outcome measures. Outcomes included patient knowledge, involvement, choice, and decisional conflict. RESULTS: The search resulted in 666 articles; most were excluded for not examining stroke prevention in atrial fibrillation and 7 studies were eventually included. Six decision aids displayed combinations of aspirin, warfarin, or no therapy; 1 included a direct oral anticoagulant. Interventions were associated with increased patient knowledge, increased likelihood of making a choice, and low decisional conflict. Use of decision aids in this review was associated with less selection of warfarin. None of the tested decision aids are currently available. DISCUSSION: Published patient decision aids for stroke prevention in atrial fibrillation are not accessible for clinical use. Given the availability of multiple comparable options, there is a need to develop and test new patient decision aids in this context.
BACKGROUND:Atrial fibrillation is a common irregular heart rhythm that increases patients' risk of stroke. Aspirin, warfarin, direct oral anticoagulants, and an implantable device can reduce this risk. Given the availability of multiple comparable options, this decision depends on patient preferences and is appropriate for the use of decision aids and other efforts to promote shared decision making. The objective of this review was to examine the existence and accessibility of, as well as select outcomes associated with, published, formally evaluated patient decision aids for stroke prevention in atrial fibrillation. METHODS: Six databases were searched from inception to March 2016 with a research librarian. Two authors independently reviewed potential articles, selected trials meeting inclusion criteria, and assessed outcome measures. Outcomes included patient knowledge, involvement, choice, and decisional conflict. RESULTS: The search resulted in 666 articles; most were excluded for not examining stroke prevention in atrial fibrillation and 7 studies were eventually included. Six decision aids displayed combinations of aspirin, warfarin, or no therapy; 1 included a direct oral anticoagulant. Interventions were associated with increased patient knowledge, increased likelihood of making a choice, and low decisional conflict. Use of decision aids in this review was associated with less selection of warfarin. None of the tested decision aids are currently available. DISCUSSION: Published patient decision aids for stroke prevention in atrial fibrillation are not accessible for clinical use. Given the availability of multiple comparable options, there is a need to develop and test new patient decision aids in this context.
Authors: Marleen Kunneman; Megan E Branda; Ian G Hargraves; Angela L Sivly; Alexander T Lee; Haeshik Gorr; Bruce Burnett; Takeki Suzuki; Elizabeth A Jackson; Erik Hess; Mark Linzer; Sarah R Brand-McCarthy; Juan P Brito; Peter A Noseworthy; Victor M Montori Journal: JAMA Intern Med Date: 2020-07-20 Impact factor: 21.873
Authors: Peter A Noseworthy; Juan P Brito; Marleen Kunneman; Ian G Hargraves; Claudia Zeballos-Palacios; Victor M Montori; Henry H Ting Journal: J Interv Card Electrophysiol Date: 2018-10-17 Impact factor: 1.900
Authors: Mina K Chung; Angela Fagerlin; Paul J Wang; Tinuola B Ajayi; Larry A Allen; Tina Baykaner; Emelia J Benjamin; Megan Branda; Kerri L Cavanaugh; Lin Y Chen; George H Crossley; Rebecca K Delaney; Lee L Eckhardt; Kathleen L Grady; Ian G Hargraves; Mellanie True Hills; Matthew M Kalscheur; Daniel B Kramer; Marleen Kunneman; Rachel Lampert; Aisha T Langford; Krystina B Lewis; Ying Lu; John M Mandrola; Kathryn Martinez; Daniel D Matlock; Sarah R McCarthy; Victor M Montori; Peter A Noseworthy; Kate M Orland; Elissa Ozanne; Rod Passman; Krishna Pundi; Dan M Roden; Elizabeth V Saarel; Monika M Schmidt; Samuel F Sears; Dawn Stacey; Randall S Stafford; Benjamin A Steinberg; Sojin Youn Wass; Jennifer M Wright Journal: Circ Arrhythm Electrophysiol Date: 2021-12-06
Authors: J C M Prick; S M van Schaik; I A Deijle; R Dahmen; P J A M Brouwers; P H E Hilkens; M M Garvelink; N Engels; J W Ankersmid; S H J Keus; R The; A Takahashi; C F van Uden-Kraan; P J van der Wees; R M Van den Berg-Vos Journal: BMC Neurol Date: 2022-07-05 Impact factor: 2.903
Authors: Claudia L Zeballos-Palacios; Ian G Hargraves; Peter A Noseworthy; Megan E Branda; Marleen Kunneman; Bruce Burnett; Michael R Gionfriddo; Christopher J McLeod; Haeshik Gorr; Juan Pablo Brito; Victor M Montori Journal: Mayo Clin Proc Date: 2019-01-11 Impact factor: 7.616
Authors: Fatima Ali-Ahmed; Karen Pieper; Rebecca North; Larry A Allen; Paul S Chan; Michael D Ezekowitz; Gregg C Fonarow; James V Freeman; Alan S Go; Bernard J Gersh; Peter R Kowey; Kenneth W Mahaffey; Gerald V Naccarelli; Sean D Pokorney; James A Reiffel; Daniel E Singer; Benjamin A Steinberg; Eric D Peterson; Jonathan P Piccini; Emily C O'Brien Journal: Eur Heart J Qual Care Clin Outcomes Date: 2020-10-01
Authors: Peter A Noseworthy; Megan E Branda; Marleen Kunneman; Ian G Hargraves; Angela L Sivly; Juan P Brito; Bruce Burnett; Claudia Zeballos-Palacios; Mark Linzer; Takeki Suzuki; Alexander T Lee; Haeshik Gorr; Elizabeth A Jackson; Erik Hess; Sarah R Brand-McCarthy; Nilay D Shah; Victor M Montori Journal: J Am Heart Assoc Date: 2022-01-13 Impact factor: 6.106
Authors: Marleen Kunneman; Megan E Branda; Ian G Hargraves; Angela L Sivly; Alexander T Lee; Haeshik Gorr; Bruce Burnett; Takeki Suzuki; Elizabeth A Jackson; Erik Hess; Mark Linzer; Sarah R Brand-McCarthy; Juan P Brito; Peter A Noseworthy; Victor M Montori Journal: JAMA Intern Med Date: 2020-09-01 Impact factor: 21.873